NCT02518191View on ClinicalTrials.gov

Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity

PHASE3CompletedINTERVENTIONAL
Enrollment

345

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

January 12, 2021

Study Completion Date

January 12, 2021

Conditions
Breast Cancer
Interventions
DRUG

GnRHa

3.6mg subcutaneous injection every 28 days.Initiated 1-2 weeks before chemotherapy and ended 4-8 weeks after chemotherapy.

Trial Locations (2)

200233

Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai

310022

Zhejiang Cancer Hospital, Hangzhou

All Listed Sponsors
collaborator

Zhejiang Cancer Hospital

OTHER

lead

Xiangyun Zong

OTHER

NCT02518191 - Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity | Biotech Hunter | Biotech Hunter